Cerecor, Inc. (NASDAQ:CERC)

About the company

Cerecor, Inc. engages in the development and commercialization of treatments for rare pediatric and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

18

CEO

Michael F. Cola

Exchange

NASDAQ

Website

http://www.cerecor.com

$7.00M

Total Revenue

18

Employees

$118.22M

Market Capitalization

-5.24

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$8M

Operating Margin (in %)

Total operating margin

$-18M

Net Margin (in %)

Total net margin

$-30M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 11600.40 1376.00 4.95 18.29 43.06
Catalent, Inc. CTLT 10838.26 2872.00 5.44 103.91 3.63
Perrigo Co. Plc PRGO 7561.03 4837.00 1.30 51.58 3.02
Bausch Health Cos., Inc. BHC 6474.02 8597.00 9.03 -3.42 -21.96
Jazz Pharmaceuticals Plc JAZZ 6255.75 2188.00 2.16 22.86 12.81
United Therapeutics Corp. UTHR 5174.19 1443.00 1.80 9.99 36.59
MyoKardia, Inc. MYOK 4329.06 34.00 12.58 -13.96 -201.73
Axsome Therapeutics, Inc. AXSM 2833.95 None 19.23 -31.51 None
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2236.52 9.00 2.63 -3.45 -413.06
Pacira Biosciences, Inc. PCRX 2199.54 435.00 5.90 -5237.00 -0.02
Corcept Therapeutics, Inc. CORT 2095.96 335.00 4.81 19.75 31.64
Prestige Consumer Healthcare, Inc. PBH 1844.67 963.00 1.55 13.01 14.77
Revolution Medicines, Inc. RVMD 1829.59 48.00 4.75 -25.84 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1673.70 0.00 4.47 -16.38 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1598.26 440.00 -22.62 18.85 19.14
Innoviva, Inc. INVA 1580.87 285.00 3.74 8.18 66.41
Intercept Pharmaceuticals, Inc. ICPT 1506.88 272.00 -44.85 -4.39 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1313.55 5.00 3.59 -3.09 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Revance Therapeutics, Inc. RVNC 1181.11 0.00 4.66 -6.33 41.82
Theravance Biopharma, Inc. TBPH 1169.64 88.00 -8.21 -4.74 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1074.08 327.00 2.68 21.08 15.90
Endo International Plc ENDP 795.72 3014.00 -1.09 -2.84 -9.09
BellRing Brands, Inc. BRBR 766.74 954.00 -0.42 5.82 13.98
Eagle Pharmaceuticals, Inc. EGRX 678.44 192.00 3.65 269.22 1.29
Assembly Biosciences, Inc. ASMB 672.22 16.00 3.01 -6.76 -601.75
Aerie Pharmaceuticals, Inc. AERI 642.62 79.00 5.10 -3.18 -252.92
Collegium Pharmaceutical, Inc. COLL 593.64 299.00 4.25 -45.95 -4.21
Anika Therapeutics, Inc. ANIK 537.18 125.00 1.86 19.38 22.73
Catalyst Pharmaceuticals, Inc. CPRX 514.67 119.00 5.01 11.73 36.09
Intersect ENT, Inc. XENT 439.36 102.00 4.15 -8.80 -48.61
BioDelivery Sciences International, Inc. BDSI 408.48 130.00 5.84 -55.50 -5.01
ANI Pharmaceuticals, Inc. ANIP 370.68 203.00 1.90 -237.62 -0.67
Albireo Pharma, Inc. ALBO 337.35 11.00 3.43 -4.41 -730.55
MEI Pharma, Inc. MEIP 289.67 5.00 4.99 -7.43 -539.48
Mallinckrodt Plc MNK 204.12 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 166.97 None 2.72 -8.09 None
Marinus Pharmaceuticals, Inc. MRNS 160.02 0.00 6.20 -2.37 None
Zynerba Pharmaceuticals, Inc. ZYNE 144.90 0.00 2.38 -4.04 -699.94
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 94.38 1.00 66.00 -5.08 None
AcelRx Pharmaceuticals, Inc. ACRX 91.20 2.00 -1.68 -1.63 -644.25
Evoke Pharma, Inc. EVOK 89.28 None 31.00 -13.29 None
Adamas Pharmaceuticals, Inc. ADMS 71.68 57.00 -4.57 -0.77 -160.44
CTI BioPharma Corp. CTIC 69.62 3.00 3.11 -1.69 -111.83
Oramed Pharmaceuticals, Inc. ORMP 63.36 3.00 5.10 -4.96 -464.15
Aclaris Therapeutics, Inc. ACRS 61.50 4.00 1.08 -0.45 None
Cassava Sciences, Inc. SAVA 54.34 41.00 2.86 -11.92 76.71
SCYNEXIS, Inc. SCYX 48.89 0.00 10.27 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.60 47.00 0.99 -10.80 -9.59
Natural Alternatives International, Inc. NAII 48.58 114.00 0.67 -12.85 -3.19
IsoRay, Inc. ISR 37.52 9.00 7.00 -11.20 -36.08
Lipocine, Inc. LPCN 36.90 0.00 8.79 -2.46 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.45 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.99 0.00 -2.68 -2.96 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.00 3.00 2.36 -1.60 -264.21
Regulus Therapeutics, Inc. RGLS 14.49 0.00 1.28 -0.68 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.43 None 1.34 -0.24 None
VIVUS, Inc. VVUS 8.69 73.00 -0.19 -0.29 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.74 19.00 1.07 -2.16 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.68 None 1.77 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.20 None 1.05 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Cerecor Inc

8d ago, source: CNN

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer ...

Cerecor Inc. Announces Closing of $37.95 Million Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares

23d ago, source: YAHOO!

ROCKVILLE, Md., June 11, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare ...

Cerecor Inc. Announces Pricing of $33,000,000 Public Offering of Common Stock

25d ago, source: YAHOO!

ROCKVILLE, Md., June 09, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare ...

Cerecor Inc. Announces Proposed Public Offering of Common Stock

26d ago, source: MarketWatch

ROCKVILLE, Jun 08, 2020 (GLOBE NEWSWIRE via COMTEX) -- ROCKVILLE, Md., June 08, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in ...

Analysts Anticipate Cerecor Inc (NASDAQ:CERC) Will Post Earnings of -$0.10 Per Share

9d ago, source: theenterpriseleader.com

Wall Street analysts forecast that Cerecor Inc (NASDAQ:CERC) will report ($0.10) earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have made estimates for Cerecor’s ...

Michael Cola Is The CEO, President & Director of Cerecor Inc. (NASDAQ:CERC) And They Just Picked Up 132% More Shares

21d ago, source: YAHOO!

Investors who take an interest in Cerecor Inc. (NASDAQ:CERC) should definitely note that the CEO, President & Director, ...

Global Nicotine Addiction Treatment Market Future…

6d ago, source: PharmiWeb

Data Bridge Market Research — Nicotine addiction treatment market is rising gradually with a healthy CAGR in the forecast period of 2019-2026. Government policies and initiatives to offer a fund to ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.